Beijing Science Sun Pharmaceutical Co Ltd
SZSE:300485
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Beijing Science Sun Pharmaceutical Co Ltd's latest stock split occurred on Jun 29, 2018
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
Before the split, Beijing Science Sun Pharmaceutical Co Ltd traded at 28.07 per share. Afterward, the share price was about 13.7805.
The adjusted shares began trading on Jun 29, 2018. This was Beijing Science Sun Pharmaceutical Co Ltd's 2nd stock split, following the previous one in Apr 26, 2016.
Global
Stock Splits Monitor
| Date | Company | Split | Pre-Split Price | Post-Split Price | |
|---|---|---|---|---|---|
|
Apr 28, 2026
|
|
Kura Sushi Inc
TSE:2695
|
2-for-1
x2
|
3565 1782.5 JPY | 1745 1745 JPY |
|
Apr 28, 2026
|
|
Sanki Engineering Co Ltd
TSE:1961
|
3-for-1
x3
|
7020 2340 JPY | 2413 2413 JPY |
|
Apr 28, 2026
|
|
Hyterra Ltd
ASX:HYT
|
65-for-64
x1.015625
|
0.015 0.0148 AUD | 0.015 0.015 AUD |
|
Apr 28, 2026
|
|
Fit Corp
TSE:1436
|
3-for-1
x3
|
4065 1340 JPY | 1269 1269 JPY |
|
Apr 28, 2026
|
|
Visual Processing Japan Co Ltd
TSE:334A
|
2-for-1
x2
|
1844 922 JPY | 965 965 JPY |
2695
1961
HYT
1436
334A
Beijing Science Sun Pharmaceutical Co Ltd
Glance View
Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 584 full-time employees. The company went IPO on 2015-06-26. The Company' products can be divided into cardiovascular series, immune regulation series, nervous system series and other natural or biotech pharmaceuticals. Its products include small capacity injection and freeze-dried powder injection.
